Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Deals and Financings

Set Alert for Deals

Integra Aims To Bolster Neurology Portfolio With J&J Codman Buy

Only a month after buying the tissue regeneration company Derma Sciences, Integra has announced a much larger acquisition for Codman Neurosurgery. The company says the buy would complement its current neurosurgery portfolio and boost its global reach.

Neurology Deals M & A

Latest From Deals

Device Week – Feb. 17, 2017

On this week's Medtech Insight podcast: US House Ways and Means Committee sets out plans for the next two years, including a review of all taxes and fees connected to the Affordable Care Act; Allergan and Hologic enter into separate big-money acquisitions in the aesthetics devices arena; a deep-dive look at the osteoporosis diagnostics market.

Regulation Policy

'Selective' JDRF Backs Israeli Injectable Blood Glucose Monitor

An Israeli start-up developing an injectable, miniature continuous blood glucose monitoring implant has secured funding from the Juvenile Diabetes Research Foundation (JDRF) to speed up product development. The investment will be used to bring GluSense closer to its first in-human clinical trial.

Diabetic Care Innovation

Hologic Stitches Medical Aesthetics Into Women's Health

Hologic is acquiring Cynosure for $1.65bn, saying medical aesthetics will complement its existing OB/GYN and women’s health businesses. It is the latest in a series of recent moves intended to accelerate Hologic’s growth.

M & A Deals

Europe's TAVR No. 4 Buys Into Mitral Valve Space

Transcatheter aortic valve replacement specialist Symetis has made its maiden acquisition, buying preclinical-stage mitral valve repair firm Middle Peak Medical.

Cardiology M & A

Allergan Pays $2bn-Plus For Zeltiq, Expanding Aesthetics Business

Zeltiq's CoolSculpting body-contouring system will be the third "pillar" in Allergan's aesthetics business, along with its existing facial aesthetics and plastic and regenerative surgery lines, the company says.

Aesthetics Deals

Anatomy Of A Medtech Carve-Out

Divesting an underperforming and/or non-core asset could help reinvigorate a medtech business. But what are the issues that arise for the sellers of those assets, as well as the buyers, during the carve-out process? Jane Hobson and Phelim O'Doherty of Baker McKenzie discuss what the common issues are and how to address them in this guest column.

Business Strategies Legal Issues

ICU Medical Completes Acquisition of Pfizer's Hospira Infusion Business

The $1bn in cash and stock deal will create a pure-play infusion therapy company with estimated revenue of about $1.45bn.

Commercial Deals

VC Deals Analysis: LabCorp Puts Money On January's Biggest Round

2017 has not got off to a bullish start, with January’s total venture financing deal value barely making it half way past last year’s level. The biggest round, at $40m, went to preterm birth risk specialist Sera Prognostics, catching the eye of the largest lab services provider in the US, LabCorp.

StartUps and SMEs Financing

M&A Analysis: Feeble Start To 2017

2017 kicked off with 12 medtech M&A acquisitions in January, a decline from the 18 M&A deals recorded in the same month last year, and two fewer than the previous month.

M & A Deals
See All